Metcy 50 Tablet SR
Images are for reference. Actual packaging may vary.
Metoprolol Succinate (47.5mg)
1 units • Other
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Medical applications
Metcy 50 Tablet SR contains Metoprolol Succinate 47.5 mg, a selective beta-1 adrenergic receptor blocker used primarily in the management of cardiovascular conditions. This sustained-release formulation ensures a gradual release of the active ingredient, providing prolonged therapeutic effects and improved patient compliance. Metoprolol Succinate acts by reducing heart rate, myocardial contractility, and cardiac output, thereby decreasing myocardial oxygen demand.
It is indicated for the treatment of hypertension, angina pectoris, and heart failure, as well as for secondary prevention following myocardial infarction. The medication helps in controlling blood pressure, reducing the frequency and severity of angina attacks, and improving survival and quality of life in patients with chronic heart failure. Metcy 50 Tablet SR should be administered once daily, preferably at the same time each day, and dosage adjustments should be made based on clinical response and tolerability.
Caution is advised in patients with bradycardia, hypotension, or certain conduction abnormalities. Common side effects may include fatigue, dizziness, and gastrointestinal disturbances. It is contraindicated in patients with severe bradycardia, cardiogenic shock, and known hypersensitivity to beta-blockers. Regular monitoring of heart rate and blood pressure is recommended during therapy.
Alcohol & phenols
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Metcy 50 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Metcy 50 Tablet SR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Metcy 50 Tablet SR is safe to use in patients with kidney disease. No dose adjustment of Metcy 50 Tablet SR is recommended.
Exercise Caution
Metcy 50 Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Metcy 50 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Metcy 50 Tablet SR may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Metcy 50 Tablet SR






